Global Molecular Influenza Test Market Growth (Status and Outlook) 2025-2031
Description
According to this study, the global Molecular Influenza Test market size will reach US$ million by 2031.
Rapid molecular assays are a kind of molecular influenza diagnostic test to detect influenza virus nucleic acids in upper respiratory tract specimens with high sensitivity (90-95%) and specificity. FDA-cleared rapid molecular assays are available that produce results in approximately 15-30 minutes. Some of these rapid molecular assays are CLIA-waived for point-of-care use.
United States market for Molecular Influenza Test is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Molecular Influenza Test is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Molecular Influenza Test is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Molecular Influenza Test players cover F. Hoffmann-La Roche, Quidel Corporation, Thermo Fisher Scientific, Abbott Laboratories, Becton, Dickinson, and Company, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LPI (LP Information)' newest research report, the “Molecular Influenza Test Industry Forecast” looks at past sales and reviews total world Molecular Influenza Test sales in 2024, providing a comprehensive analysis by region and market sector of projected Molecular Influenza Test sales for 2025 through 2031. With Molecular Influenza Test sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Molecular Influenza Test industry.
This Insight Report provides a comprehensive analysis of the global Molecular Influenza Test landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Molecular Influenza Test portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Molecular Influenza Test market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Molecular Influenza Test and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Molecular Influenza Test.
This report presents a comprehensive overview, market shares, and growth opportunities of Molecular Influenza Test market by product type, application, key players and key regions and countries.
Segmentation by Type:
RT-PCR
TMA
LAMP
NASBA
Other
Segmentation by Application:
Hospitals
Clinical Laboratories
Other End-User
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
F. Hoffmann-La Roche
Quidel Corporation
Thermo Fisher Scientific
Abbott Laboratories
Becton, Dickinson, and Company
DiaSorin
bioMérieux
Please note: The report will take approximately 2 business days to prepare and deliver.
Rapid molecular assays are a kind of molecular influenza diagnostic test to detect influenza virus nucleic acids in upper respiratory tract specimens with high sensitivity (90-95%) and specificity. FDA-cleared rapid molecular assays are available that produce results in approximately 15-30 minutes. Some of these rapid molecular assays are CLIA-waived for point-of-care use.
United States market for Molecular Influenza Test is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
China market for Molecular Influenza Test is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Europe market for Molecular Influenza Test is estimated to increase from US$ million in 2024 to US$ million by 2031, at a CAGR of % from 2025 through 2031.
Global key Molecular Influenza Test players cover F. Hoffmann-La Roche, Quidel Corporation, Thermo Fisher Scientific, Abbott Laboratories, Becton, Dickinson, and Company, etc. In terms of revenue, the global two largest companies occupied for a share nearly % in 2024.
LPI (LP Information)' newest research report, the “Molecular Influenza Test Industry Forecast” looks at past sales and reviews total world Molecular Influenza Test sales in 2024, providing a comprehensive analysis by region and market sector of projected Molecular Influenza Test sales for 2025 through 2031. With Molecular Influenza Test sales broken down by region, market sector and sub-sector, this report provides a detailed analysis in US$ millions of the world Molecular Influenza Test industry.
This Insight Report provides a comprehensive analysis of the global Molecular Influenza Test landscape and highlights key trends related to product segmentation, company formation, revenue, and market share, latest development, and M&A activity. This report also analyses the strategies of leading global companies with a focus on Molecular Influenza Test portfolios and capabilities, market entry strategies, market positions, and geographic footprints, to better understand these firms’ unique position in an accelerating global Molecular Influenza Test market.
This Insight Report evaluates the key market trends, drivers, and affecting factors shaping the global outlook for Molecular Influenza Test and breaks down the forecast by Type, by Application, geography, and market size to highlight emerging pockets of opportunity. With a transparent methodology based on hundreds of bottom-up qualitative and quantitative market inputs, this study forecast offers a highly nuanced view of the current state and future trajectory in the global Molecular Influenza Test.
This report presents a comprehensive overview, market shares, and growth opportunities of Molecular Influenza Test market by product type, application, key players and key regions and countries.
Segmentation by Type:
RT-PCR
TMA
LAMP
NASBA
Other
Segmentation by Application:
Hospitals
Clinical Laboratories
Other End-User
This report also splits the market by region:
Americas
United States
Canada
Mexico
Brazil
APAC
China
Japan
Korea
Southeast Asia
India
Australia
Europe
Germany
France
UK
Italy
Russia
Middle East & Africa
Egypt
South Africa
Israel
Turkey
GCC Countries
The below companies that are profiled have been selected based on inputs gathered from primary experts and analyzing the company's coverage, product portfolio, its market penetration.
F. Hoffmann-La Roche
Quidel Corporation
Thermo Fisher Scientific
Abbott Laboratories
Becton, Dickinson, and Company
DiaSorin
bioMérieux
Please note: The report will take approximately 2 business days to prepare and deliver.
Table of Contents
100 Pages
- *This is a tentative TOC and the final deliverable is subject to change.*
Pricing
Currency Rates
Questions or Comments?
Our team has the ability to search within reports to verify it suits your needs. We can also help maximize your budget by finding sections of reports you can purchase.
